首页 > 最新文献

Journal of Korean Medical Science最新文献

英文 中文
The Combined Effects of Alcohol Consumption and Smoking on Cancer Risk by Exposure Level: A Systematic Review and Meta-Analysis. 按暴露水平划分的饮酒和吸烟对癌症风险的综合影响:系统回顾与元分析》。
IF 4.5 3区 医学 Q1 Medicine Pub Date : 2024-06-10 DOI: 10.3346/jkms.2024.39.e185
Seunghee Jun, Hyunjin Park, Ui-Jeong Kim, Hye Ah Lee, Bomi Park, Soon Young Lee, Sun Ha Jee, Hyesook Park

Background: Alcohol consumption is a major risk factor for cancer, and when combined with smoking, the risk increases. Nevertheless, few studies have comprehensively evaluated the combined effects of alcohol consumption and smoking on the risk of various cancer types. Therefore, to assess these effects, we conducted a systematic review and meta-analysis.

Methods: We performed a systematic search of five literature databases, focusing on cohort and case-control studies. Considering exposure levels, we quantified the combined effects of alcohol consumption and smoking on cancer risk and assessed multiplicative interaction effects.

Results: Of 4,452 studies identified, 24 (4 cohort studies and 20 case-control studies) were included in the meta-analysis. We detected interaction effect of light alcohol and moderate smoking on head and neck cancer risk (relative risk [RR], 4.26; 95% confidence interval [CI], 2.50-7.26; I² = 65%). A synergistic interaction was observed in heavy alcohol and heavy smoking group (RR, 35.24; 95% CI, 23.17-53.58; I² = 69%). In more detailed cancer types, the interaction effect of heavy alcohol and heavy smoking was noticeable on oral (RR, 36.42; 95% CI, 24.62-53.87; I² = 46%) and laryngeal (RR, 38.75; 95% CI, 19.25-78.01; I² = 69%) cancer risk.

Conclusion: Our study provided a comprehensive summary of the combined effects of alcohol consumption and smoking on cancers. As their consumption increased, the synergy effect became more pronounced, and the synergy effect was evident especially for head and neck cancer. These findings provide additional evidence for the combined effect of alcohol and smoking in alcohol guidelines for cancer prevention.

背景:饮酒是罹患癌症的一个主要风险因素,如果同时吸烟,则罹患癌症的风险会增加。然而,很少有研究全面评估了饮酒和吸烟对各种癌症风险的综合影响。因此,为了评估这些影响,我们进行了系统回顾和荟萃分析:我们对五个文献数据库进行了系统检索,重点关注队列研究和病例对照研究。考虑到暴露水平,我们量化了饮酒和吸烟对癌症风险的综合影响,并评估了乘法交互效应:在已确定的 4452 项研究中,有 24 项(4 项队列研究和 20 项病例对照研究)纳入了荟萃分析。我们发现了轻度酒精和中度吸烟对头颈部癌症风险的交互效应(相对风险 [RR],4.26;95% 置信区间 [CI],2.50-7.26;I² = 65%)。在大量饮酒和大量吸烟组中观察到了协同交互作用(RR,35.24;95% CI,23.17-53.58;I² = 69%)。在更详细的癌症类型中,大量饮酒和大量吸烟对口腔癌(RR,36.42;95% CI,24.62-53.87;I² = 46%)和喉癌(RR,38.75;95% CI,19.25-78.01;I² = 69%)风险的交互作用非常明显:我们的研究全面总结了饮酒和吸烟对癌症的综合影响。随着饮酒量的增加,协同效应变得更加明显,尤其是在头颈部癌症方面。这些发现为预防癌症的酒精指南中酒精和吸烟的联合效应提供了更多证据。
{"title":"The Combined Effects of Alcohol Consumption and Smoking on Cancer Risk by Exposure Level: A Systematic Review and Meta-Analysis.","authors":"Seunghee Jun, Hyunjin Park, Ui-Jeong Kim, Hye Ah Lee, Bomi Park, Soon Young Lee, Sun Ha Jee, Hyesook Park","doi":"10.3346/jkms.2024.39.e185","DOIUrl":"10.3346/jkms.2024.39.e185","url":null,"abstract":"<p><strong>Background: </strong>Alcohol consumption is a major risk factor for cancer, and when combined with smoking, the risk increases. Nevertheless, few studies have comprehensively evaluated the combined effects of alcohol consumption and smoking on the risk of various cancer types. Therefore, to assess these effects, we conducted a systematic review and meta-analysis.</p><p><strong>Methods: </strong>We performed a systematic search of five literature databases, focusing on cohort and case-control studies. Considering exposure levels, we quantified the combined effects of alcohol consumption and smoking on cancer risk and assessed multiplicative interaction effects.</p><p><strong>Results: </strong>Of 4,452 studies identified, 24 (4 cohort studies and 20 case-control studies) were included in the meta-analysis. We detected interaction effect of light alcohol and moderate smoking on head and neck cancer risk (relative risk [RR], 4.26; 95% confidence interval [CI], 2.50-7.26; <i>I</i>² = 65%). A synergistic interaction was observed in heavy alcohol and heavy smoking group (RR, 35.24; 95% CI, 23.17-53.58; <i>I</i>² = 69%). In more detailed cancer types, the interaction effect of heavy alcohol and heavy smoking was noticeable on oral (RR, 36.42; 95% CI, 24.62-53.87; <i>I</i>² = 46%) and laryngeal (RR, 38.75; 95% CI, 19.25-78.01; <i>I</i>² = 69%) cancer risk.</p><p><strong>Conclusion: </strong>Our study provided a comprehensive summary of the combined effects of alcohol consumption and smoking on cancers. As their consumption increased, the synergy effect became more pronounced, and the synergy effect was evident especially for head and neck cancer. These findings provide additional evidence for the combined effect of alcohol and smoking in alcohol guidelines for cancer prevention.</p>","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2024-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11164648/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141300838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Will the Massacre of Substandard Medical Schools Be Reproduced in Korea, Like the Flexner Report-Related Precedent in the United States? 不合格医学院的大屠杀是否会在韩国重演,就像美国与《弗莱克斯纳报告》相关的先例一样?
IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-06-10 DOI: 10.3346/jkms.2024.39.e184
Jin-Hong Yoo
{"title":"Will the Massacre of Substandard Medical Schools Be Reproduced in Korea, Like the Flexner Report-Related Precedent in the United States?","authors":"Jin-Hong Yoo","doi":"10.3346/jkms.2024.39.e184","DOIUrl":"10.3346/jkms.2024.39.e184","url":null,"abstract":"","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11164653/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141300840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expert Consensus on the Structure, Role, and Procedures of the Korea Expert Committee on Immunization Practices. 关于韩国免疫实践专家委员会的结构、作用和程序的专家共识。
IF 4.5 3区 医学 Q1 Medicine Pub Date : 2024-06-03 DOI: 10.3346/jkms.2024.39.e166
Cho Ryok Kang, Bin Ahn, Young June Choe, So Yun Lim, Han Wool Kim, Hyun Mi Kang, Ji Young Park, Hyungmin Lee, Seungho Lee, Sumin Jeong, Sunghee Kwon, Eun Hwa Choi

Background: The Korea Expert Committee on Immunization Practices (KECIP) is a key advisory body the government to develop guidelines and provide technical advisory activities on immunization policies in Korea. A recent policy study, inspired by global best practices, aims to enhance KECIP's functionality for providing timely and transparent recommendations in the face of evolving vaccine science and emerging infectious diseases like COVID-19.

Methods: This study reviewed the current status of KECIP and collected expert opinions through surveys and consultations. Among the 40 panel members who were surveyed, 19 responded to a questionnaire specifically designed to assess the potential areas of improvement within KECIP.

Results: The majority of respondents favored maintaining the current member count and emphasized the need for a subcommittee. Opinions varied on issues such as the length of KECIP's term, the representation of vaccine manufacturers' perspectives, and the chairperson's role. However, there was a consensus on the importance of expertise, transparency, and fair proceedings within the committee.

Conclusion: This study underscores the pivotal role of KECIP in shaping national immunization policies, emphasizing the necessity for informed guidance amidst evolving vaccine science and emerging infectious diseases. Furthermore, it stressed the importance of enhancing KECIP's capacity to effectively address evolving public health challenges and maintain successful immunization programs in South Korea.

背景:韩国免疫实践专家委员会(KECIP)是韩国政府的一个重要咨询机构,负责为韩国的免疫政策制定指导方针并提供技术咨询。最近的一项政策研究受到全球最佳实践的启发,旨在加强 KECIP 的功能,以便在疫苗科学不断发展和 COVID-19 等新出现的传染病面前提供及时、透明的建议:本研究审查了 KECIP 的现状,并通过调查和咨询收集了专家意见。在接受调查的 40 名专家组成员中,有 19 人回答了专门为评估 KECIP 潜在改进领域而设计的调查问卷:结果:大多数受访者赞成维持目前的成员人数,并强调了成立小组委员会的必要性。对于 KECIP 的任期、疫苗生产商观点的代表性以及主席的作用等问题,意见不一。不过,在委员会内部专业知识、透明度和公平程序的重要性方面,各方达成了共识:本研究强调了 KECIP 在制定国家免疫政策中的关键作用,强调了在不断发展的疫苗科学和新出现的传染病中提供知情指导的必要性。此外,它还强调了加强 KECIP 能力的重要性,以有效应对不断变化的公共卫生挑战,并在韩国保持成功的免疫接种计划。
{"title":"Expert Consensus on the Structure, Role, and Procedures of the Korea Expert Committee on Immunization Practices.","authors":"Cho Ryok Kang, Bin Ahn, Young June Choe, So Yun Lim, Han Wool Kim, Hyun Mi Kang, Ji Young Park, Hyungmin Lee, Seungho Lee, Sumin Jeong, Sunghee Kwon, Eun Hwa Choi","doi":"10.3346/jkms.2024.39.e166","DOIUrl":"10.3346/jkms.2024.39.e166","url":null,"abstract":"<p><strong>Background: </strong>The Korea Expert Committee on Immunization Practices (KECIP) is a key advisory body the government to develop guidelines and provide technical advisory activities on immunization policies in Korea. A recent policy study, inspired by global best practices, aims to enhance KECIP's functionality for providing timely and transparent recommendations in the face of evolving vaccine science and emerging infectious diseases like COVID-19.</p><p><strong>Methods: </strong>This study reviewed the current status of KECIP and collected expert opinions through surveys and consultations. Among the 40 panel members who were surveyed, 19 responded to a questionnaire specifically designed to assess the potential areas of improvement within KECIP.</p><p><strong>Results: </strong>The majority of respondents favored maintaining the current member count and emphasized the need for a subcommittee. Opinions varied on issues such as the length of KECIP's term, the representation of vaccine manufacturers' perspectives, and the chairperson's role. However, there was a consensus on the importance of expertise, transparency, and fair proceedings within the committee.</p><p><strong>Conclusion: </strong>This study underscores the pivotal role of KECIP in shaping national immunization policies, emphasizing the necessity for informed guidance amidst evolving vaccine science and emerging infectious diseases. Furthermore, it stressed the importance of enhancing KECIP's capacity to effectively address evolving public health challenges and maintain successful immunization programs in South Korea.</p>","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2024-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11147785/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141237768","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Appreciation of Invisible Intellectual Contributions. 赞赏无形的智力贡献。
IF 4.5 3区 医学 Q1 Medicine Pub Date : 2024-06-03 DOI: 10.3346/jkms.2024.39.e183
Jin-Hong Yoo
{"title":"Appreciation of Invisible Intellectual Contributions.","authors":"Jin-Hong Yoo","doi":"10.3346/jkms.2024.39.e183","DOIUrl":"10.3346/jkms.2024.39.e183","url":null,"abstract":"","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2024-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11147788/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141237761","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection by Type and Frequency of Vaccine: A Community-Based Case-Control Study. 按疫苗类型和接种频率划分的预防严重急性呼吸系统综合征冠状病毒 2 再感染的疫苗效力:一项基于社区的病例对照研究。
IF 4.5 3区 医学 Q1 Medicine Pub Date : 2024-06-03 DOI: 10.3346/jkms.2024.39.e174
Hyerin Gim, Haesook Seo, Byung Chul Chun

Background: Although guidelines recommend vaccination for individuals who have recovered from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection to prevent reinfection, comprehensive evaluation studies are limited. We aimed to evaluate vaccine effectiveness against SARS-CoV-2 reinfection according to the primary vaccination status, booster vaccination status, and vaccination methods used.

Methods: This population-based case-control study enrolled all SARS-CoV-2-infected patients in Seoul between January 2020 and February 2022. Individuals were categorized into case (reinfection) and control (no reinfection) groups. Data were analyzed using conditional logistic regression after adjusting for underlying comorbidities using multiple regression.

Results: The case group included 7,678 participants (average age: 32.26 years). In all vaccinated individuals, patients who received the first and second booster doses showed reduced reinfection rates compared with individuals who received basic vaccination (odds ratio [OR] = 0.605, P < 0.001 and OR = 0.002, P < 0.001). Patients who received BNT162b2 or mRNA-1273, NVX-CoV2373 and heterologous vaccination showed reduced reinfection rates compared with unvaccinated individuals (OR = 0.546, P < 0.001; OR = 0.356, P < 0.001; and OR = 0.472, P < 0.001). However, the ChAdOx1-S or Ad26.COV2.S vaccination group showed a higher reinfection rate than the BNT162b2 or mRNA-1273 vaccination group (OR = 4.419, P < 0.001).

Conclusion: In SARS-CoV-2-infected individuals, completion of the basic vaccination series showed significant protection against reinfection compared with no vaccination. If the first or second booster vaccination was received, the protective effect against reinfection was higher than that of basic vaccination; when vaccinated with BNT162b2 or mRNA-1273 only or heterologous vaccination, the protective effect was higher than that of ChAdOx1-S or Ad26.COV2.S vaccination only.

背景:尽管指南建议已从严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)感染中康复的人接种疫苗以预防再感染,但全面的评估研究却很有限。我们的目的是根据初次接种情况、加强接种情况和接种方法来评估疫苗预防 SARS-CoV-2 再感染的效果:这项基于人群的病例对照研究招募了 2020 年 1 月至 2022 年 2 月期间首尔的所有 SARS-CoV-2 感染者。患者被分为病例组(再感染)和对照组(无再感染)。在使用多元回归对基础合并症进行调整后,使用条件逻辑回归对数据进行分析:病例组包括 7678 名参与者(平均年龄:32.26 岁)。在所有接种者中,接种第一和第二剂加强剂的患者与接种基本疫苗的患者相比,再感染率有所降低(几率比 [OR] = 0.605,P < 0.001;OR = 0.002,P < 0.001)。与未接种疫苗的患者相比,接种 BNT162b2 或 mRNA-1273、NVX-CoV2373 和异源疫苗的患者再感染率较低(OR = 0.546,P < 0.001;OR = 0.356,P < 0.001;OR = 0.472,P < 0.001)。然而,ChAdOx1-S 或 Ad26.COV2.S 疫苗接种组的再感染率高于 BNT162b2 或 mRNA-1273 疫苗接种组(OR = 4.419,P < 0.001):结论:在 SARS-CoV-2 感染者中,完成基本疫苗接种系列与不接种相比,可显著预防再感染。结论:在 SARS-CoV-2 感染者中,完成基本疫苗接种系列与未接种相比,对再感染的保护效果显著。如果接种第一或第二次加强免疫,对再感染的保护效果高于基本疫苗接种;如果仅接种 BNT162b2 或 mRNA-1273 或异源疫苗,保护效果高于仅接种 ChAdOx1-S 或 Ad26.COV2.S 疫苗。
{"title":"Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection by Type and Frequency of Vaccine: A Community-Based Case-Control Study.","authors":"Hyerin Gim, Haesook Seo, Byung Chul Chun","doi":"10.3346/jkms.2024.39.e174","DOIUrl":"10.3346/jkms.2024.39.e174","url":null,"abstract":"<p><strong>Background: </strong>Although guidelines recommend vaccination for individuals who have recovered from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection to prevent reinfection, comprehensive evaluation studies are limited. We aimed to evaluate vaccine effectiveness against SARS-CoV-2 reinfection according to the primary vaccination status, booster vaccination status, and vaccination methods used.</p><p><strong>Methods: </strong>This population-based case-control study enrolled all SARS-CoV-2-infected patients in Seoul between January 2020 and February 2022. Individuals were categorized into case (reinfection) and control (no reinfection) groups. Data were analyzed using conditional logistic regression after adjusting for underlying comorbidities using multiple regression.</p><p><strong>Results: </strong>The case group included 7,678 participants (average age: 32.26 years). In all vaccinated individuals, patients who received the first and second booster doses showed reduced reinfection rates compared with individuals who received basic vaccination (odds ratio [OR] = 0.605, <i>P</i> < 0.001 and OR = 0.002, <i>P</i> < 0.001). Patients who received BNT162b2 or mRNA-1273, NVX-CoV2373 and heterologous vaccination showed reduced reinfection rates compared with unvaccinated individuals (OR = 0.546, <i>P</i> < 0.001; OR = 0.356, <i>P</i> < 0.001; and OR = 0.472, <i>P</i> < 0.001). However, the ChAdOx1-S or Ad26.COV2.S vaccination group showed a higher reinfection rate than the BNT162b2 or mRNA-1273 vaccination group (OR = 4.419, <i>P</i> < 0.001).</p><p><strong>Conclusion: </strong>In SARS-CoV-2-infected individuals, completion of the basic vaccination series showed significant protection against reinfection compared with no vaccination. If the first or second booster vaccination was received, the protective effect against reinfection was higher than that of basic vaccination; when vaccinated with BNT162b2 or mRNA-1273 only or heterologous vaccination, the protective effect was higher than that of ChAdOx1-S or Ad26.COV2.S vaccination only.</p>","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2024-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11147786/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141237843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In This Issue on 03-June-2024. 本期日期:2024 年 6 月 3 日。
IF 4.5 3区 医学 Q1 Medicine Pub Date : 2024-06-03 DOI: 10.3346/jkms.2024.39.e180
Jin-Hong Yoo
{"title":"In This Issue on 03-June-2024.","authors":"Jin-Hong Yoo","doi":"10.3346/jkms.2024.39.e180","DOIUrl":"10.3346/jkms.2024.39.e180","url":null,"abstract":"","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2024-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11147789/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141237769","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Credibility of the P Value. P 值的可信度。
IF 4.5 3区 医学 Q1 Medicine Pub Date : 2024-06-03 DOI: 10.3346/jkms.2024.39.e177
Farrokh Habibzadeh
{"title":"Credibility of the <i>P</i> Value.","authors":"Farrokh Habibzadeh","doi":"10.3346/jkms.2024.39.e177","DOIUrl":"10.3346/jkms.2024.39.e177","url":null,"abstract":"","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2024-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11147784/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141237763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Impact of an Antimicrobial Stewardship Program on Days of Therapy in the Pediatric Center: An Interrupted Time-Series Analysis of a 19-Year Study. 抗菌药物管理计划对儿科中心治疗天数的影响:19年研究的间断时间序列分析。
IF 4.5 3区 医学 Q1 Medicine Pub Date : 2024-06-03 DOI: 10.3346/jkms.2024.39.e172
Kyung-Ran Kim, Hyo Jung Park, Sun-Young Baek, Soo-Han Choi, Byung-Kee Lee, SooJin Kim, Jong Min Kim, Ji-Man Kang, Sun-Ja Kim, Sae Rom Choi, Dongsub Kim, Joon-Sik Choi, Yoonsun Yoon, Hwanhee Park, Doo Ri Kim, Areum Shin, Seonwoo Kim, Yae-Jean Kim

Background: We aimed to analyze the effects of an antimicrobial stewardship program (ASP) on the proportion of antimicrobial-resistant pathogens in bacteremia, antimicrobial use, and mortality in pediatric patients.

Methods: A retrospective single-center study was performed on pediatric inpatients under 19 years old who received systemic antimicrobial treatment from 2001 to 2019. A pediatric infectious disease attending physician started ASP in January 2008. The study period was divided into the pre-intervention (2001-2008) and the post-intervention (2009-2019) periods. The amount of antimicrobial use was defined as days of therapy per 1,000 patient-days, and the differences were compared using delta slope (= changes in slopes) between the two study periods by an interrupted time-series analysis. The proportion of resistant pathogens and the 30-day overall mortality rate were analyzed by the χ².

Results: The proportion of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae bacteremia increased from 17% (39 of 235) in the pre-intervention period to 35% (189 of 533) in the post-intervention period (P < 0.001). The total amount of antimicrobial use significantly decreased after the introduction of ASP (delta slope value = -16.5; 95% confidence interval [CI], -30.6 to -2.3; P = 0.049). The 30-day overall mortality rate in patients with bacteremia did not increase, being 10% (55 of 564) in the pre-intervention and 10% (94 of 941) in the post-intervention period (P = 0.881).

Conclusion: The introduction of ASP for pediatric patients reduced the delta slope of the total antimicrobial use without increasing the mortality rate despite an increased incidence of ESBL-producing gram-negative bacteremia.

背景:我们旨在分析抗菌药物管理计划(ASP)对儿科患者菌血症中耐药病原体比例、抗菌药物使用和死亡率的影响:对2001年至2019年期间接受全身抗菌治疗的19岁以下儿科住院患者进行了一项回顾性单中心研究。一名儿科传染病主治医师于 2008 年 1 月启动了 ASP。研究期间分为干预前(2001-2008 年)和干预后(2009-2019 年)。抗菌药物使用量定义为每 1,000 个患者日中的治疗天数,通过间断时间序列分析,使用 delta 坡度(= 坡度变化)比较两个研究期间的差异。耐药病原体的比例和30天总死亡率用χ²进行分析:结果:产生广谱β-内酰胺酶(ESBL)的大肠埃希菌和肺炎克雷伯菌菌血症的比例从干预前的 17%(235 例中的 39 例)增加到干预后的 35%(533 例中的 189 例)(P < 0.001)。引入 ASP 后,抗菌药物使用总量显著下降(delta 斜坡值 = -16.5;95% 置信区间 [CI],-30.6 至 -2.3;P = 0.049)。菌血症患者的 30 天总死亡率没有增加,干预前为 10%(564 例中的 55 例),干预后为 10%(941 例中的 94 例)(P = 0.881):结论:尽管产ESBL革兰氏阴性菌血症的发生率有所上升,但对儿科患者采用ASP减少了抗菌药物总使用量的delta斜率,而死亡率却没有增加。
{"title":"The Impact of an Antimicrobial Stewardship Program on Days of Therapy in the Pediatric Center: An Interrupted Time-Series Analysis of a 19-Year Study.","authors":"Kyung-Ran Kim, Hyo Jung Park, Sun-Young Baek, Soo-Han Choi, Byung-Kee Lee, SooJin Kim, Jong Min Kim, Ji-Man Kang, Sun-Ja Kim, Sae Rom Choi, Dongsub Kim, Joon-Sik Choi, Yoonsun Yoon, Hwanhee Park, Doo Ri Kim, Areum Shin, Seonwoo Kim, Yae-Jean Kim","doi":"10.3346/jkms.2024.39.e172","DOIUrl":"10.3346/jkms.2024.39.e172","url":null,"abstract":"<p><strong>Background: </strong>We aimed to analyze the effects of an antimicrobial stewardship program (ASP) on the proportion of antimicrobial-resistant pathogens in bacteremia, antimicrobial use, and mortality in pediatric patients.</p><p><strong>Methods: </strong>A retrospective single-center study was performed on pediatric inpatients under 19 years old who received systemic antimicrobial treatment from 2001 to 2019. A pediatric infectious disease attending physician started ASP in January 2008. The study period was divided into the pre-intervention (2001-2008) and the post-intervention (2009-2019) periods. The amount of antimicrobial use was defined as days of therapy per 1,000 patient-days, and the differences were compared using delta slope (= changes in slopes) between the two study periods by an interrupted time-series analysis. The proportion of resistant pathogens and the 30-day overall mortality rate were analyzed by the χ².</p><p><strong>Results: </strong>The proportion of extended-spectrum beta-lactamase (ESBL)-producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> bacteremia increased from 17% (39 of 235) in the pre-intervention period to 35% (189 of 533) in the post-intervention period (<i>P</i> < 0.001). The total amount of antimicrobial use significantly decreased after the introduction of ASP (delta slope value = -16.5; 95% confidence interval [CI], -30.6 to -2.3; <i>P</i> = 0.049). The 30-day overall mortality rate in patients with bacteremia did not increase, being 10% (55 of 564) in the pre-intervention and 10% (94 of 941) in the post-intervention period (<i>P</i> = 0.881).</p><p><strong>Conclusion: </strong>The introduction of ASP for pediatric patients reduced the delta slope of the total antimicrobial use without increasing the mortality rate despite an increased incidence of ESBL-producing gram-negative bacteremia.</p>","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2024-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11147790/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141237842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lessons From the Household Humidifier Disinfectant Tragedy (HHDT) With Focus on the Chemical Poisoning Surveillance System: Review and Recommendation. 从家用加湿器消毒剂悲剧(HHDT)中吸取的教训,重点是化学中毒监测系统:回顾与建议。
IF 4.5 3区 医学 Q1 Medicine Pub Date : 2024-06-03 DOI: 10.3346/jkms.2024.39.e178
Dong-Uk Park, Thomas H Gassert, Kyung Ehi Zoh, Dong Young Lee, Fabrizio Sesana, Soyoung Park, Seong-Yong Yoon

Background: Lessons learned from the Household Humidifier Disinfectant Tragedy (HHDT) in Korea, which poisoned thousands of citizens over a period of years, necessitated an examination of national poison prevention and surveillance systems. The objectives of this study are to identify essential changes needed in chemical poisoning prevention regulations and surveillance systems for effective poison control by comparing recent trends in international poison control center (PCC) operations, and to delineate the critical elements for establishing a state-of-the-art poison control surveillance system in Korea based on recent advances in PCCs with toxicovigilance.

Methods: A comprehensive review of Korea's regulatory and surveillance systems for chemical health hazards, with a focus on household products under the HHDT, was conducted. A review of toxicovigilance systems in major countries shows that creating an effective national PCC requires key elements: a centralized database of toxic substances and poisoning cases, mandatory or voluntary reporting of poisoning cases, real-time alerts, collaboration among health organizations, and targeted follow-up of poisoned individuals.

Results: Significant deficiencies in Korea's legislation, toxicological data management, and poisoning surveillance systems, explained the inadequate response of the Korean government to the HHDT for nearly 17 years until the end of 2011. Based on a review of PCC toxicovigilance systems in major countries, a national framework with five core components is recommended for establishing a modern comprehensive Korea PCC system with toxicovigilance capacity. The core components include establishment of a centralized database of toxic substances information and clinical poisoning cases, implementation of mandatory or permissive reporting of poisoning cases, real-time alert mechanisms, collaborative systems among health-related organizations, and clinical follow-up of poisoned sub-groups.

Conclusion: A rationale and framework for a state-of-the-art national Korean PCC with toxicovigilance is justified and offered. This proposed system could assist neighboring countries in establishing their own sophisticated, globally integrated PCC networks.

背景:韩国的家用加湿器消毒剂悲剧(HHDT)在数年内造成了数千名公民中毒,从这一悲剧中吸取的教训促使我们有必要对国家毒物预防和监控系统进行审查。本研究的目的是通过比较国际毒物控制中心(PCC)运作的最新趋势,确定有效毒物控制所需的化学品中毒预防法规和监控系统的基本变化,并根据毒物控制中心与毒物警戒的最新进展,界定在韩国建立最先进的毒物控制监控系统的关键要素:方法:对韩国的化学品健康危害监管和监测系统进行了全面审查,重点是 HHDT 下的家用产品。对主要国家毒物警戒系统的回顾表明,建立一个有效的国家 PCC 需要具备以下关键要素:有毒物质和中毒病例的中央数据库、中毒病例的强制或自愿报告、实时警报、卫生机构之间的合作以及对中毒者进行有针对性的跟踪:韩国在立法、毒物数据管理和中毒监测系统方面存在重大缺陷,这也是韩国政府在截至 2011 年底的近 17 年中对 HHDT 反应不足的原因。在对主要国家的 PCC 毒物警戒系统进行回顾的基础上,建议建立一个包含五个核心组成部分的国家框架,以建立一个具有毒物警戒能力的现代化综合韩国 PCC 系统。这些核心内容包括建立有毒物质信息和临床中毒病例的中央数据库、实施中毒病例的强制或许可报告、实时警报机制、卫生相关组织之间的协作系统以及中毒亚群体的临床跟踪:结论:本文论证并提出了韩国最先进的全国中毒监测中心的基本原理和框架。这一拟议系统可帮助周边国家建立自己先进的全球一体化 PCC 网络。
{"title":"Lessons From the Household Humidifier Disinfectant Tragedy (HHDT) With Focus on the Chemical Poisoning Surveillance System: Review and Recommendation.","authors":"Dong-Uk Park, Thomas H Gassert, Kyung Ehi Zoh, Dong Young Lee, Fabrizio Sesana, Soyoung Park, Seong-Yong Yoon","doi":"10.3346/jkms.2024.39.e178","DOIUrl":"10.3346/jkms.2024.39.e178","url":null,"abstract":"<p><strong>Background: </strong>Lessons learned from the Household Humidifier Disinfectant Tragedy (HHDT) in Korea, which poisoned thousands of citizens over a period of years, necessitated an examination of national poison prevention and surveillance systems. The objectives of this study are to identify essential changes needed in chemical poisoning prevention regulations and surveillance systems for effective poison control by comparing recent trends in international poison control center (PCC) operations, and to delineate the critical elements for establishing a state-of-the-art poison control surveillance system in Korea based on recent advances in PCCs with toxicovigilance.</p><p><strong>Methods: </strong>A comprehensive review of Korea's regulatory and surveillance systems for chemical health hazards, with a focus on household products under the HHDT, was conducted. A review of toxicovigilance systems in major countries shows that creating an effective national PCC requires key elements: a centralized database of toxic substances and poisoning cases, mandatory or voluntary reporting of poisoning cases, real-time alerts, collaboration among health organizations, and targeted follow-up of poisoned individuals.</p><p><strong>Results: </strong>Significant deficiencies in Korea's legislation, toxicological data management, and poisoning surveillance systems, explained the inadequate response of the Korean government to the HHDT for nearly 17 years until the end of 2011. Based on a review of PCC toxicovigilance systems in major countries, a national framework with five core components is recommended for establishing a modern comprehensive Korea PCC system with toxicovigilance capacity. The core components include establishment of a centralized database of toxic substances information and clinical poisoning cases, implementation of mandatory or permissive reporting of poisoning cases, real-time alert mechanisms, collaborative systems among health-related organizations, and clinical follow-up of poisoned sub-groups.</p><p><strong>Conclusion: </strong>A rationale and framework for a state-of-the-art national Korean PCC with toxicovigilance is justified and offered. This proposed system could assist neighboring countries in establishing their own sophisticated, globally integrated PCC networks.</p>","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2024-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11147787/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141237841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Brief Review of Anatomy Education in Korea, Encompassing Its Past, Present, and Future Direction. 简要回顾韩国解剖学教育的过去、现在和未来。
IF 4.5 3区 医学 Q1 Medicine Pub Date : 2024-05-27 DOI: 10.3346/jkms.2024.39.e159
In-Beom Kim, Kyeung Min Joo, Chang Ho Song, Im Joo Rhyu

Anatomy is a foundational subject in medicine and serves as its language. Hippocrates highlighted its importance, while Herophilus pioneered human dissection, earning him the title of the founder of anatomy. Vesalius later established modern anatomy, which has since evolved historically. In Korea, formal anatomy education for medical training began with the introduction of Western medicine during the late Joseon Dynasty. Before and after the Japanese occupation, anatomy education was conducted in the German style, and after liberation, it was maintained and developed by a small number of domestic anatomists. Medicine in Korea has grown alongside the country's rapid economic and social development. Today, 40 medical colleges produce world-class doctors to provide the best medical care service in the country. However, the societal demand for more doctors is growing in order to proactively address to challenges such as public healthcare issues, essential healthcare provision, regional medical service disparities, and an aging population. This study examines the history, current state, and challenges of anatomy education in Korea, emphasizing the availability of medical educators, support staff, and cadavers for gross anatomy instruction. While variations exist between Seoul and provincial medical colleges, each manages to deliver adequate education under challenging conditions. However, the rapid increase in medical student enrollment threatens to strain existing anatomy education resources, potentially compromising educational quality. To address these concerns, we propose strategies for training qualified gross anatomy educators, ensuring a sustainable cadaver supply, and enhancing infrastructure.

解剖学是医学的基础学科,也是医学的语言。希波克拉底强调了解剖学的重要性,而希罗菲勒斯则开创了人体解剖学,被誉为解剖学的奠基人。维萨里后来建立了现代解剖学,并在此后经历了历史性的演变。在韩国,正规的医学培训解剖学教育始于朝鲜王朝末期西医的传入。在日本占领前后,解剖学教育是按照德国风格进行的,解放后由少数国内解剖学家保持和发展。随着经济和社会的快速发展,韩国的医学也在不断发展。如今,40 所医学院培养出世界一流的医生,为韩国提供最好的医疗服务。然而,为了积极应对公共医疗保健问题、基本医疗保健服务、地区医疗服务差距和人口老龄化等挑战,社会对更多医生的需求也在不断增长。本研究探讨了韩国解剖学教育的历史、现状和挑战,强调了医学教育工作者、辅助人员和尸体的可用性,以便进行解剖学教学。虽然首尔和各省的医学院之间存在差异,但每所医学院都能在充满挑战的条件下提供充分的教育。然而,医学生入学人数的快速增长有可能使现有的解剖学教育资源捉襟见肘,进而影响教育质量。为了解决这些问题,我们提出了培训合格的解剖学教育工作者、确保可持续的尸体供应和加强基础设施建设的策略。
{"title":"A Brief Review of Anatomy Education in Korea, Encompassing Its Past, Present, and Future Direction.","authors":"In-Beom Kim, Kyeung Min Joo, Chang Ho Song, Im Joo Rhyu","doi":"10.3346/jkms.2024.39.e159","DOIUrl":"10.3346/jkms.2024.39.e159","url":null,"abstract":"<p><p>Anatomy is a foundational subject in medicine and serves as its language. Hippocrates highlighted its importance, while Herophilus pioneered human dissection, earning him the title of the founder of anatomy. Vesalius later established modern anatomy, which has since evolved historically. In Korea, formal anatomy education for medical training began with the introduction of Western medicine during the late Joseon Dynasty. Before and after the Japanese occupation, anatomy education was conducted in the German style, and after liberation, it was maintained and developed by a small number of domestic anatomists. Medicine in Korea has grown alongside the country's rapid economic and social development. Today, 40 medical colleges produce world-class doctors to provide the best medical care service in the country. However, the societal demand for more doctors is growing in order to proactively address to challenges such as public healthcare issues, essential healthcare provision, regional medical service disparities, and an aging population. This study examines the history, current state, and challenges of anatomy education in Korea, emphasizing the availability of medical educators, support staff, and cadavers for gross anatomy instruction. While variations exist between Seoul and provincial medical colleges, each manages to deliver adequate education under challenging conditions. However, the rapid increase in medical student enrollment threatens to strain existing anatomy education resources, potentially compromising educational quality. To address these concerns, we propose strategies for training qualified gross anatomy educators, ensuring a sustainable cadaver supply, and enhancing infrastructure.</p>","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2024-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11136677/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141158238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Korean Medical Science
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1